MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during Fibrosis

In fibrotic diseases, myofibroblasts derive from a range of cell types including endothelial-to-mesenchymal transition (EndMT). Increasing evidence suggests that miRNAs are key regulators in biological processes but their profile is relatively understudied in EndMT. In human umbilical vein endothelial cells (HUVEC), EndMT was induced by treatment with TGFβ2 and IL1β. A significant decrease in endothelial markers such as VE-cadherin, CD31 and an increase in mesenchymal markers such as fibronectin were observed. In parallel, miRNA profiling showed that miR-126-3p was down-regulated in HUVECs undergoing EndMT and over-expression of miR-126-3p prevented EndMT, maintaining CD31 and repressing fibronectin expression. EndMT was investigated using lineage tracing with transgenic Cdh5-Cre-ERT2; Rosa26R-stop-YFP mice in two established models of fibrosis: cardiac ischaemic injury and kidney ureteric occlusion. In both cardiac and kidney fibrosis, lineage tracing showed a significant subpopulation of endothelial-derived cells expressed mesenchymal markers, indicating they had undergone EndMT. In addition, miR-126-3p was restricted to endothelial cells and down-regulated in murine fibrotic kidney and heart tissue. These findings were confirmed in patient kidney biopsies. MiR-126-3p expression is restricted to endothelial cells and is down-regulated during EndMT. Over-expression of miR-126-3p reduces EndMT, therefore, it could be considered for miRNA-based therapeutics in fibrotic organs.

[1]  M. Nicholson,et al.  MicroRNA-126-3p is Downregulated in Human Kidneys in a Model of Reperfusion Injury , 2020, Kidney International Reports.

[2]  V. LeBleu,et al.  Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis , 2020, Science Signaling.

[3]  E. Rondeau,et al.  Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allografts , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  Gwo-Bin Lee,et al.  Two-step magnetic bead-based (2MBB) techniques for immunocapture of extracellular vesicles and quantification of microRNAs for cardiovascular diseases: A pilot study , 2020, PloS one.

[5]  N. Sheerin,et al.  Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction , 2018, Pediatric Nephrology.

[6]  Yaqiu Guo,et al.  Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo , 2017, Oncotarget.

[7]  A. Medvinsky,et al.  Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis , 2017, Stem cell reports.

[8]  Y. B. Sun,et al.  The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. , 2016, Differentiation; research in biological diversity.

[9]  A. Fornace,et al.  Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response , 2016, PloS one.

[10]  M. Zeisberg,et al.  Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells* , 2015, The Journal of Biological Chemistry.

[11]  Hae-June Lee,et al.  A Hypoxia-Induced Vascular Endothelial-to-Mesenchymal Transition in Development of Radiation-Induced Pulmonary Fibrosis , 2015, Clinical Cancer Research.

[12]  T. Rabelink,et al.  Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. , 2014, Journal of the American Society of Nephrology : JASN.

[13]  D. Brenner,et al.  Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.

[14]  Y. Ishigaki,et al.  Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen , 2014, Diabetes.

[15]  L. Gesualdo,et al.  Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  R. Virmani,et al.  TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling , 2014, Science Translational Medicine.

[17]  Changqian Wang,et al.  microRNA 126 Inhibits the Transition of Endothelial Progenitor Cells to Mesenchymal Cells via the PIK3R2-PI3K/Akt Signalling Pathway , 2013, PloS one.

[18]  R. Kalluri,et al.  Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.

[19]  M. Goumans,et al.  MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition. , 2012, MicroRNA.

[20]  Yan Wang,et al.  Human Circulating MicroRNA-1 and MicroRNA-126 as Potential Novel Indicators for Acute Myocardial Infarction , 2012, International journal of biological sciences.

[21]  N. Chatauret,et al.  New strategies to optimize kidney recovery and preservation in transplantation , 2012, Nature Reviews Nephrology.

[22]  T. Thum,et al.  Transforming Growth Factor-&bgr;–Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21 , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[23]  C. A. de la Motte,et al.  Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. , 2011, The American journal of pathology.

[24]  Raghu Kalluri,et al.  Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. , 2011, The Biochemical journal.

[25]  O. Celhay,et al.  Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy , 2010, Transplantation.

[26]  A. Barberis,et al.  Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis , 2010, Nature.

[27]  R. Formica,et al.  Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[29]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[30]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[31]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[32]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[33]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[34]  M. Maleszewska.  From microenvironment to epigenetics in endothelial cells , 2015 .

[35]  N. Milman,et al.  Outcome of lung transplanted patients with primary graft dysfunction. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.